Astellas Sues Roxane Labs Over Generic Version of Billion-Dollar Cancer Drug Xtandi

Astellas Pharma filed suit against generics makers Roxane Laboratories, West-Ward Pharmaceuticals and Hikma Pharmaceuticals over their copycat version of Xtandi.
Source: Drug Industry Daily